Trial intelligence / Profile preview

PLANET 1: Rosuvastatin vs Atorvastatin in Diabetic Proteinuria

NCT00296374Phase 2Completed

Sponsor
AstraZeneca
Start
Feb 2006
Primary completion
Mar 2009
Modality
Orthosteric Ligands
Countries
11
01

Overview

A Phase 2 trial of rosuvastatin in hypercholesterolemia, sponsored by AstraZeneca. Started Feb 2006; status: completed.

02

Drugs

rosuvastatin
03

Conditions

hypercholesterolemia

Beyond the preview

Go deeper on NCT00296374.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00296374.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call